Exchange: OTC·Updated 02:20 PM EDT

TBIO Telesis Bio Inc

$0.001
$0.00
(0.00%)
Today
Reported EarningsAug 7
Mkt Cap$78,394.00
Vol645.00

About TBIO

Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
54

Neutral Sentiment

How do you feel about TBIO?

Advertisement|Remove ads.